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Background: The benefit of carotid endarterectomy (CEA) over best medical therapy was established using intra-arterial
angiography (IAA) for patient selection. Its cost, availability, and risk together with the emergence of newer imaging
modalities have led to its replacement in the routine assessment of internal carotid artery (ICA) stenosis. The relative
performance of these methods should dictate the optimum imaging strategy in symptomatic patients.
Methods: A previous meta-analysis (NIHR Health Technology Assessment Programme) was reviewed. Medline and
PubMed search was performed for relevant publications since 2006 together with a review of the references in retrieved
publications.
Results: Compared to IAA, the sensitivity and specificity for noninvasive imaging of a >70% to 99% ICA stenosis are
duplex ultrasound (DUS): 0.89 (0.85-0.92) and 0.84 (0.77-0.89); time-of-flight magnetic resonance angiography
(TOF-MRA): 0.88 (0.82-0.92) and 0.84 (0.76-0.97); contrast-enhanced MRA (CE-MRA): 0.94 (0.88-0.97) and 0.93
(0.89-0.96); and computed tomography angiography: 0.77 (0.68-0.84) and 0.95 (0.91-0.97), respectively. A policy of
initial DUS followed by confirmatory CE-MRA best matches patient selection by arteriography. Single modality imaging
for 50% to 69% ICA stenoses suggests reduced reliability resulting in more inappropriate operations.
Conclusions:DUS is the optimum screening tool due to its sensitivity and specificity, availability, and low cost. When CEA
appears indicated, confirmatory imaging with CE-MRA is the most reliable and cost-effective method of investigation.
(J Vasc Surg 2011;54:1215-8.)
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bAround 15% of cerebral infarctions are caused by ca-
rotid disease, and when a transient ischemic attack (TIA) or
minor stroke is attributable to a significant internal carotid
artery (ICA) stenosis, there is a high short-term risk of
disabling stroke.1,2 This can be reduced by fast tracking
appropriate patients to carotid endarterectomy (CEA). In
the majority of patients, duplex ultrasound (DUS) is used
as the initial, and sometimes the only investigation, to
identify advanced extracranial atherosclerosis. Alterna-
tively, DUS is used as a screening tool with subsequent
confirmatory imaging before selecting patients for surgery.
Although the benefit of CEA over best medical therapy
for patients with a 50% to 69% (less benefit) or a 70%
(greater benefit) ICA stenosis was established using intra-
arterial angiography (IAA), use of the latter has rapidly
declined because of greater expense and risk (stroke, other
adverse events)3 compared to DUS, computed tomogra-
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doi:10.1016/j.jvs.2011.05.101hy (CT) angiography, and either contrast-enhanced mag-
etic resonance angiography (CE-MRA) or time-of-flight
agnetic resonance angiography (TOF-MRA). Given the
idespread adoption of noninvasive imaging modalities, it
s crucial that their sensitivity and specificity in relation to
AA be established to ensure appropriate selection of pa-
ients for CEA. Further, it is clear that a new “gold stan-
ard” is required for assessment of carotid disease.
ETHODS
A previous meta-analysis (NIHR Health Technology
ssessment Programme4), of which the current author was
co-author, has been reviewed. In addition, a Medline and
ubMed search was performed for relevant publications
ince 2006 together with a review of the references in
etrieved publications.
ESULTS
Imaging techniques. DUS is well established and
enerally considered reliable in assessing carotid disease.
he low false negative rate makes it an ideal first line
nvestigation. Further, it may provide information about
laque structure. However, the flow velocity criteria for
rading ICA stenosis have not been standardized, and this
ill influence the results obtained.5-7 This was highlighted
yWalker andNaylor in 20068 and subsequently suggested
rotocols for carotid DUSwere published.9 Finally, there is
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October 20111216 Goughthe inherent variability between practitioners undertaking
DUS, and their performance should be regularly moni-
tored against another imaging modality, particularly in
centers where CEA is advised on the basis of DUS alone.
MRA time-of-flight methods have largely been re-
placed by CE-MRA (shorter acquisition times, lesser ten-
dency to overestimate stenosis, fewer movement artifacts).
The wide field of view allows identification of both proxi-
mal and distal tandem lesions although performance may
be inferior to IAA for the latter.10 Many technical refine-
ments (surface coils, contrast agents, sequence modifica-
tion) have been described making comparison of studies
difficult although most aim to facilitate identification of
high-risk unstable plaques.
CT angiography (CTA) has a similar field of view to
CE-MRA but higher spatial resolution withmultislice scan-
ners. However, artifacts from calcified plaques are common
and contrast agents may be contraindicated in patients with
impaired renal function. Dual energy CT (bone suppres-
sion, 3D imaging) and 320-slice imaging are likely to
enhance its future value.
Performance of imaging techniques. In general,
noninvasive imaging is less accurate for lesser degrees of
stenosis, and this is of concern given the current drive for
semiacute CEA in symptomatic patients and the trend to
refer patients with a 50% to 69% stenosis within 14 days of
the index event. Although this has increased the number of
patients submitted to surgery, the use of less accurate
imaging methods will also influence workload and the
efficacy of stroke prevention. However, further trials com-
paring noninvasive imaging with IAA are unlikely (expen-
sive, potentially unethical), and this is endorsed by the lack
Table I. Data from meta-analysis11: sensitivity and specific
for 70%-99% ICA stenosis
Investigation Patients Arteries
DUS 316 568
MRA 264 396
CE-MRA 124 326
CTA 111 185
CE-MRA, Contrast-enhanced magnetic resonance angiography; CTA, co
angiography; ICA, internal carotid artery; MRA, magnetic resonance angio
a95% confidence intervals.
Table II. Data from meta-analysis11: sensitivity and specifi
for 50%-69% ICA stenosis
Investigation Patients Arteries
DUS 62 61
MRA 63 78
CE-MRA 26 47
CTA 6 10
CE-MRA, Contrast-enhanced magnetic resonance angiography; CTA, co
angiography; ICA, internal carotid artery; MRA, magnetic resonance angio
a95% confidence intervals.of comparative studies since a meta-analysis of 41 reports g1980-2004) comparing IAA and noninvasive imaging was
ublished in 2006.11
A striking feature of the review was that 631 studies
ere excluded from analysis because of changing DUS
echnology (161), poor methodology and reporting (239)
nd because they were preliminary descriptions of new
echniques.
A summary of the findings are shown in Tables I and II.
he authors considered the data for 70% to 99% ICA
tenoses to be robust and to demonstrate that CE-MRA
nd DUS have a higher sensitivity than CTA, but the latter
better specificity. These techniques were less reliable in
he assessment of 50% to 69% ICA stenoses although there
ere less data available for comparison.
Similarly the meta-analysis included a low number of
lderly patients where vessel tortuosity and calcification
ight affect performance, and most studies were per-
ormed in specialist centers reporting new techniques. Per-
ormance in the wider clinical environment rarely matches
hat of the initial reports and the true sensitivity and spec-
ficity is often lower.
Further publications and cost-effectiveness. Wardlaw
t al11 indicated that five relatively small studies that did not
lter their conclusions were published between the end of
heir review (2004) and publication of their findings in
006. One that reported sensitivities and specificities for
US (88%, 76%) and MRA (92, 76%) and combined
oncordant imaging (96%, 80%) also assessed cost-effec-
iveness.12 The authors concluded that DUS alone was
ost cost-effective and that adding MRA only marginally
mproved performance at prohibitive cost. Interestingly, a
ecent study reached the same conclusion for CTA13 sug-
r noninvasive imaging techniques compared with IAA
Sensitivitya Specificitya
0.89 (0.85-0.92) 0.84 (0.77-0.89)
0.88 (0.82-0.92) 0.84 (0.76-0.97)
0.94 (0.88-0.97) 0.93 (0.89-0.96)
0.77 (0.68-0.84) 0.95 (0.91-0.97)
d tomography angiography; DUS, duplex ultrasound; IAA, intra-arterial
y.
for non-invasive imaging techniques compared with IAA
Sensitivitya Specificitya
0.36 (0.25-0.49) 0.91 (0.87-0.94)
0.37 (0.26-0.49) 0.91 (0.78-0.97)
0.77 (0.59-0.89) 0.97 (0.93-0.99)
0.67 (0.30-0.90) 0.79 (0.63-0.89)
d tomography angiography; DUS, duplex ultrasound; IAA, intra-arterial
y.ity fo
mputecity
mputeesting that it was used as an additional investigation rather
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undergoing CEA. Given the widely held belief that patients
should undergo two noninvasive investigations prior to
CEA, these criticisms are not justified. Conversely, a further
study supported dual imaging concluding that combining
DUS and CE-MRA was the most cost-effective method
being the cheapest (when IAA was the alternative) and
yielding more quality-adjusted life years.14
Implications of a strategy of noninvasive imaging.
Following the meta-analysis. the same group created a
model15 based on data derived from the systematic review
and an individual patient meta-analysis16 to assess the im-
pact of different strategies on workload and stroke preven-
tion. Only the sensitivity and specificity of CTA changed
after adding the additional patient data (0.76 and 0.94,
respectively).
For the United Kingdom, data relating to delays prior
to CEA are outdated and will not be considered further.
Nevertheless, to provide CEA within 14 days of the index
event, hospitals must offer “on demand” access to high
quality noninvasive carotid imaging, particularly when clin-
ical decision-makingmight require two or even three (if the
first two are discordant) investigations.
The model revealed some interesting differences in the
proportion of patients selected for CEA depending upon
the imaging methods employed. Using a protocol of DUS
(50%-99% stenosis) followed by IAA confirming a 70% to
99% stenosis, 5.9% of patients would be referred for endar-
terectomy. However, there was a fivefold variation in refer-
ral rates for CEA depending on whether single or dual
imaging was adopted and the % stenosis at which this was
advised. The data are summarized in Table III.
Although the study reports disturbing findings for
strategies involving a single imagingmodality, performance
was significantly improved when two imaging techniques
were used. This reduced the proportion of patients under-
going CEA to 6.6% to 8.0% for MRA, CE-MRA, and CTA
when preceded by DUS compared with 5.4% to 5.9% for
protocols that included IAA. While many authors suggest
that two DUS examinations are sufficient for patient selec-
tion, this may lead to twice as many surgical referrals
(around 15%) compared with the other dual imaging strat-
egies. Thus, it seems logical to screen patients with DUS,
and if a potentially significant stenosis is identified, this
should be confirmed with either CE-MRA or CTA. As a
note of caution, however, the meta-analysis from which the
data derived for this study was obtained stressed that it was
difficult to extract comparative data for patients who were
undergoing two noninvasive imaging methods because this
was rarely provided in the original papers. Nevertheless,
since CE-MRA has the highest sensitivity and specificity, it
seems logical to use DUS initially (thus, overestimating the
number of patients whomight benefit from CEA) followed
by CE-MRA to positively select patients for surgery.
Although the choice of imaging might seem straight-
forward, the authors also looked at the data in a slightly
different way by calculating the number of strokes that
would occur/100 TIA patients within 1 year of the index svent taking into account the influence of risk prevention,
he number undergoing surgery, and the imaging modality
sed. The Fig presents a summary of the information for
ingle modality imaging. Thus, fewest strokes will occur
fter DUS although more patients will have undergone
nnecessary surgery.
ISCUSSION
Future developments. Although it might seem that a
able III. Proportion of patients offered CEA
epending on imaging strategy and % ICA stenosis
derived from Wardlaw et al15)
maging strategy
Number CEAs/100
patients with TIA/minor stroke
ingle modality
S 70%-99% then surgery 17.1
S 50%-99% then surgery 24.7
E-MRA 70%-99% then surgery 6.9
E-MRA 50%-99% then surgery 12.8
TA 70%-99% then surgery 26.0
TA 50%-99% then surgery 7.2
ual modality
S 70%-99% then US; if
70%-99%, then surgery
15.5
S 50%-99% then IAA; if
70%-99%, then surgery
5.9
S 70%-99% then IAA; if
70%-99%, then surgery
5.4
S 70%-99% then MRA; if
agree, then surgery
8.0
S 70%-99% then CTA; if
agree, then surgery
6.6
EA, Carotid endarterectomy; CE-MRA, contrast-enhanced magnetic res-
nance angiography; CTA, computed tomography angiography; IAA,
ntra-arterial angiography; ICA, internal carotid artery; MRA, magnetic
esonance angiography; TIA, transient ischemic attack; US, ultrasound.
ig. Number of strokes at 1 year per 100 transient ischemic attack
TIA) patients following a strategy of single modality imaging and
arotid endarterectomy (CEA) at 14 days (derived from Wardlaw
t al15). CE-MRA, Contrast-enhanced magnetic resonance an-
iography; CTA, computed tomography angiography; DUS, du-
lex ultrasound; MRA, magnetic resonance angiography.trategy for investigating patients with carotid atheroscle-
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continual changes in technology is exemplified by the re-
cent description of an eight-channel phased array coil,
designed specifically for imaging the carotid bifurcation.
Although the authors believe that this will prove superior to
CE-MRA imaging,17 careful evaluation of all new technol-
ogy in well-designed studies is vital.
In addition, although current patient selection for CEA
is based upon %ICA stenosis, there is continuing work on
developing methods to identify unstable carotid plaques.
Ultimately, certain characteristics (large lipid core, intra-
plaque hemorrhage, thin or ruptured fibrous caps) may
allow selection of patients who are likely to gain the maxi-
mum benefit from surgery, and the sensitivity and specific-
ity of these techniques may become as important as those
for assessing the % ICA stenosis.
CONCLUSIONS
IAA has only a peripheral role in assessing patients with
a suspected ICA stenosis and DUS provides the optimum
screening method provided that appropriate velocity crite-
ria are used and technicians are regularly revalidated. CE-
MRA appears to be the most accurate noninvasive modality
for assessing ICA narrowing and should be used in combi-
nation with an initial DUS in the selection of patients for
CEA. Arguably CE-MRA should now be regarded as the
gold standard for carotid imaging. In patients where DUS
and CE-MRA are discordant, CTA is an appropriate arbi-
ter.8
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